Qelbree

viloxazine hydrochloride · Capsule, Extended Release · Oral

Prescription (Rx) Norepinephrine Reuptake Inhibitor

No FDA structured label text is available for Qelbree. The NDC listings below come from the FDA National Drug Code directory.

Active ingredients

Qelbree NDC products (3)

NDCStrength & formLabelerType
17772-131Viloxazine Hydrochloride 100 mg/1
Capsule, Extended Release
Supernus Pharmaceuticals, IncNDA
17772-132Viloxazine Hydrochloride 150 mg/1
Capsule, Extended Release
Supernus Pharmaceuticals, IncNDA
17772-133Viloxazine Hydrochloride 200 mg/1
Capsule, Extended Release
Supernus Pharmaceuticals, IncNDA

Frequently asked questions

Who makes Qelbree?

Qelbree is listed by 1 labeler in the FDA NDC directory, including Supernus Pharmaceuticals, Inc.